Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

Starting soon · Phase 2

Conditions studied: Infertility

In brief

The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation

Key facts

Study ID

NCT07569289

Run by

Bedaya Hospital

People needed

164

Starts

2026-06-01

Expected to finish

2028-04-01

Last updated by the study team

2026-05-06

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• POSEIDON group 3 and 4
• GnRH antagonist IVF cycle

You may not qualify if…

• Hypogonadotrophic hypogonadism
• Endometriosis
• History of recurrent abortion

Where it is running

• Bedaya Hospital — Giza, Giza Governorate, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.